Bioactive 3D-Printed valve scaffold promoting valvular regeneration via immunomodulation and endothelialization.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42494754.
- Also identified by DOI 10.1016/j.bioactmat.2026.07.021 and PMC identifier 13393579.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The <i>in vivo</i> performance of tissue-engineered heart valves remains constrained by a persistent early failure triad at the blood-material interface, namely thrombosis, unresolved inflammation, and slow endothelialization. Here, a bioinstructive multilayer valve scaffold is engineered to address these interfacial barriers through spatially integrated structural and biological functions. The scaffold comprises a digitally programmable 3D-printed framework, a silk fibroin wrapping layer, and a hydrogel biointerface incorporating Arg-Gly-Asp/GelMA adhesive cues together with H<sub>2</sub>S-releasing microgels. This layered design endows the construct with valve-relevant tensile properties while simultaneously programming the immune-endothelial microenvironment. The hydrogel biointerface promotes endothelial migration, proliferation, and angiogenic activity, whereas sustained H<sub>2</sub>S delivery biases macrophages toward a pro-resolving M2-like phenotype and suppresses inflammatory activation. Transcriptomic analysis further reveals coordinated upregulation of endothelial programs related to endothelial repair, migration, and proliferation, accompanied by attenuation of stress- and inflammation-associated responses. <i>In vivo</i>, the scaffold mitigates thromboinflammatory reactions, shows preliminary anti-calcification performance, and supports endothelialization under blood-contacting conditions. Together, this work establishes a layered bioactive engineering approach that converts a passive 3D-printed structural scaffold into a regenerative, hemocompatible, and immunoregulatory biofunctional valve scaffold. This strategy offers a promising design principle for the further development of regenerative valve scaffolds.